Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 125Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/altamira-therapeutics-announces-allowance-of-japanese-patent-applicat-1048826

ACCESSWIRE
15 Jul 2025

https://www.globenewswire.com//news-release/2023/11/10/2778332/0/en/Altamira-Therapeutics-Announces-European-Patent-Office-Decision-to-Grant-for-Patent-Application-Covering-Intranasal-Betahistine.html

GLOBENEWSWIRE
10 Nov 2023

https://www.accesswire.com/viewarticle.aspx?id=748222&lang=en

ACCESSWIRE
10 Apr 2023

http://www.globenewswire.com/news-release/2019/07/03/1877879/0/en/Auris-Medical-Completes-Enrollment-of-Phase-1b-Proof-Of-Concept-Trial-of-AM-201-in-Antipsychotic-Induced-Weight-Gain.html

GLOBE NEWSWIRE
03 Jul 2019

https://www.pharmacompass.com/pdf/news/ema-recommends-suspension-of-medicines-due-to-unreliable-studies-from-micro-therapeutic-research-labs-1503552764.pdf

EMA
23 Aug 2017

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58558r-eng.php

HEALTH CANADA
12 May 2016